toxicity-screens-human-retinal-organoids-for-pharmaceutical

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Organoids provide a promising platform to study disease mechanism and treatments, directly in the context of human tissue with the versatility and ...

Lowy Medical Research Institute

The Scripps Research Institute

Identifying mechanisms of diseases with complex inheritance patterns, such as macular telangiectasia type 2, is challenging. A link between macular telangiectasia type 2 and altered serine metabolism has been established previously.

Sarah Harkins-Perry

Lowy Medical Research Institute

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery